Guadecitabine Plus Atezolizumab for Metastatic Urothelial Carcinoma Resistant to Initial ICI Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy
Clin. Cancer Res 2023 Mar 16;[EPub Ahead of Print], HJ Jang, G Hostetter, AW MacFarlane, Z Madaj, EA Ross, T Hinoue, JR Kulchycki, RS Burgos, M Tafseer, RK Alpaugh, CL Schwebel, R Kokate, DM Geynisman, MR Zibelman, P Ghatalia, PW Nichols, W Chung, J Madzo, NM Hahn, DI Quinn, JJ Issa, MJ Topper, SB Baylin, H Shen, KS Campbell, PA Jones, ER PlimackFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.